A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization

David Peterhoff, Vivian Glück, Matthias Vogel, +31

Infection

Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale

Steven Schmitt, Manuel Montalbán‐López, David Peterhoff, +5

Nature Chemical Biology

Nanoliter ScaleAntibacterial AgentAntimicrobial CompoundAntimicrobial ResistanceDrug Resistance

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

Julián Valero, Laia Civit, Daniel M. Dupont, +13

Proceedings of the National Academy of Sciences

ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

Esther Dreier, Maximilian Malfertheiner, Thomas Dienemann, +14

Perfusion

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

Vivian Glück, Sonja Grobecker, Leonid Tydykov, +9

Infection

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2

Stilla Bauernfeind, Bernd Salzberger, Florian Hitzenbichler, +6

Vaccines

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel

Vivian Glück, Sonja Grobecker, Josef Köstler, +12

Infection

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

Duško Lainšček, Tina Fink, Vida Forstnerič, +25

Vaccines

Rbd DomainEngineeringImmunologyImmunodominanceImmunotherapeutics +20

Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020

Ralf Wagner, David Peterhoff, Stephanie Beileke, +20

Viruses

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals

Anna-Lena Mader, Leonid Tydykov, Vivian Glück, +16

iScience